Cargando…
Hypoxia-Inducible Ubiquitin Specific Peptidase 13 Contributes to Tumor Growth and Metastasis via Enhancing the Toll-Like Receptor 4/Myeloid Differentiation Primary Response Gene 88/Nuclear Factor-κB Pathway in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death worldwide. The activation of the toll-like receptor 4/myeloid differentiation primary response gene 88/nuclear factor-κB (TLR4/MyD88/NF-κB) pathway contributes to the development and progression of HCC. The ubiquitin–proteas...
Autores principales: | Gao, Shan, Chen, Tianxiang, Li, Lijie, Liu, Xin, Liu, Yang, Zhao, Junjun, Lu, Qiliang, Zeng, Zhi, Xu, Qiuran, Huang, Dongsheng, Tu, Kangsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604352/ https://www.ncbi.nlm.nih.gov/pubmed/33195243 http://dx.doi.org/10.3389/fcell.2020.587389 |
Ejemplares similares
-
HIF-1/2α-Activated RNF146 Enhances the Proliferation and Glycolysis of Hepatocellular Carcinoma Cells via the PTEN/AKT/mTOR Pathway
por: Shen, Guoliang, et al.
Publicado: (2022) -
Role of Ubiquitin-Specific Peptidase 47 in Cancers and Other Diseases
por: Pan, Kailing, et al.
Publicado: (2021) -
Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
por: Zeng, Zhi, et al.
Publicado: (2021) -
Paying the Toll in Nuclear Reprogramming
por: Liu, Chun, et al.
Publicado: (2017) -
A Novel Lactate Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironment in Hepatocellular Carcinoma
por: Li, Yue, et al.
Publicado: (2022)